New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
Needham & Company LLC reissued their hold rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research ...
If you purchased or otherwise own TransMedics Group securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at ...
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -6.6% (gross) and -6.8 ...
Learn more about whether Bausch + Lomb Corporation or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
In truth, it appears that TransMedics fueled its growth by engaging in an anti-competitive scheme, including providing kickbacks to medical providers. The company further boosted growth by engaging in ...
CENTRAL TRUST Co lifted its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 162.2% in the 4th quarter, ...
NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics ...
Learn more about whether Inspire Medical Systems, Inc. or TransMedics Group, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and the release of a short-seller report. Data demonstrates that the ...
During the last three months, 8 analysts shared their evaluations of TransMedics Gr (NASDAQ:TMDX), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...